Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2021-05-10
Target enrollment:
Participant gender:
Summary
Patients with diabetes are susceptible to dementia, but regular therapy fails to reduce the
risk of dementia. In previous observational study, the investigators found that liraglutide
can improve cognitive function in patients with T2DM through a metabolism-independent
pathway. Here the investigators aim to further verify such effects through a randomized,
controlled study.